Sign in
Explore the registryTrack Pembrolizumab berahyaluronidase alfa's trials

A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

Pembrolizumab (+) Berahyaluronidase alfaOngoingActive not recruitingPhase 3Open NCT06698042 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…